Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding

M. Alderman, K. Arakawa, L. Beilin, J. Chalmers, Jay N Cohn, R. Collins, R. R. Fenichel, E. D. Frohlich, P. Hamet, L. Hansson, C. Hennekens, E. Kuschnir, L. Lisheng, S. MacMahon, G. Mancia, I. Martin, J. Menard, P. Sleight, J. Whitworth, S. YusufA. Zanchetti, B. Neal

Research output: Contribution to journalShort survey

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)61-72
Number of pages12
JournalHypertension Research - Clinical and Experimental
Volume20
Issue number2
StatePublished - Sep 3 1997

Cite this

Alderman, M., Arakawa, K., Beilin, L., Chalmers, J., Cohn, J. N., Collins, R., Fenichel, R. R., Frohlich, E. D., Hamet, P., Hansson, L., Hennekens, C., Kuschnir, E., Lisheng, L., MacMahon, S., Mancia, G., Martin, I., Menard, J., Sleight, P., Whitworth, J., ... Neal, B. (1997). Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Hypertension Research - Clinical and Experimental, 20(2), 61-72.